Fear of cancer recurrence therapy (FORT): A randomized controlled trial - PubMed This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecologic...

📢 Our FORT RCT on fear of cancer recurrence (Maheu et al., Health Psychol) has now been cited 24 times!

Grateful for the interest in this national program for cancer survivors’ mental health well-being.
📄 pubmed.ncbi.nlm.nih.gov/36862474/
#FCR #psychoncology #Hindex20